Skip to main content
. Author manuscript; available in PMC: 2018 Sep 17.
Published in final edited form as: Science. 2016 Nov 4;354(6312):618–622. doi: 10.1126/science.aag0299

Table 1. Mutational signatures and cancer types associated with tobacco smoking.

Information about the age adjusted odds ratios for current male smokers to develop cancer is taken from refs. (24). Odds ratios for small cell lung cancer, lung squamous and lung adenocarcinoma are for an average daily dose of more than 30 cigarettes. Odds ratios for cervix and ovary are for current female smokers. Detailed information about all mutation types, all mutational signatures and DNA methylation is provided in Table S2. Nomenclature for signature IDs is consistent with the COSMIC website, http://cancer.sanger.ac.uk/cosmic/signatures. The patterns of all mutational signatures with elevated mutation burden in smokers are displayed in Fig. 2B. N/A denotes lack of smoking annotation for a given cancer type. * denotes that a signature correlates with pack years smoked in a cancer type.

Cancer Type Odds ratios Non-smokers Smokers Total number of mutational signatures found in the cancer type Signature 4 found in cancer type Mutational signatures with elevated mutation burden in smokers compared to non-smokers (q-value<0.05)
All Cancer Types 1,062 2,490 26 Y 4, 5*
Small Cell Lung Cancer 111.3 3 145 6 Y
Lung Squamous 103.5 7 168 8 Y 4*, 5
Lung Adenocarcinoma 21.9 120 558 7 Y 2*, 4*, 5*, 13*
Larynx 13.2 6 117 5 Y 4*, 5
Pharynx 6.6 27 49 5 Y 5*
Oral Cavity 4.2 98 265 5 Y 5*
Esophagus Squamous 3.9 99 193 9 Y 5
Esophagus Adenocarcinoma 3.9 67 175 9 Y
Bladder 3.8 111 288 5 N 5*
Liver 2.9 157 235 19 Y 4*, 5, 16
Stomach 2.1 472 13 N N/A
Acute Myeloid Leukemia 2.0 202 2 N N/A
Ovary 1.9 458 3 N N/A
Cervix 1.8 94 74 8 N
Kidney 1.7 154 103 6 N 5
Pancreas 1.6 119 120 11 N
Colorectal 1.3 559 4 N N/A
HHS Vulnerability Disclosure